| - GRCh37:
- Chr11:44135775
- GRCh38:
- Chr11:44114225
| EXT2 | R223W, R256W | Exostoses, multiple, type 2, Exostoses, multiple, type 2, Seizures-scoliosis-macrocephaly syndrome, not provided | Uncertain significance (Sep 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:44253909
- GRCh38:
- Chr11:44232359
| EXT2 | R567W, R557W, R590W | Exostoses, multiple, type 2, Seizures-scoliosis-macrocephaly syndrome, Exostoses, multiple, type 2
| Uncertain significance (Aug 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:44146536
- GRCh38:
- Chr11:44124986
| EXT2 | | Seizures-scoliosis-macrocephaly syndrome | Likely pathogenic (Jul 29, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:44228353
- GRCh38:
- Chr11:44206803
| EXT2 | W502*, W512*, W535* | Exostoses, multiple, type 2, Seizures-scoliosis-macrocephaly syndrome | Likely pathogenic (Sep 7, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:44193294
- GRCh38:
- Chr11:44171744
| EXT2 | | not provided, Seizures-scoliosis-macrocephaly syndrome, Exostoses, multiple, type 2
| Likely pathogenic (Sep 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:44193164
- GRCh38:
- Chr11:44171614
| EXT2 | R393W, R426W | Exostoses, multiple, type 2, Seizures-scoliosis-macrocephaly syndrome | Uncertain significance (May 3, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:44257852
- GRCh38:
- Chr11:44236302
| EXT2 | R682*, R649*, R659* | Exostoses, multiple, type 2, Exostoses, multiple, type 2, Seizures-scoliosis-macrocephaly syndrome, not provided | Conflicting interpretations of pathogenicity (May 31, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:44151688
- GRCh38:
- Chr11:44130138
| EXT2 | | Seizures-scoliosis-macrocephaly syndrome | Likely pathogenic (Jun 21, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:44129644
- GRCh38:
- Chr11:44108094
| EXT2 | R128W, R161W | Exostoses, multiple, type 2, Seizures-scoliosis-macrocephaly syndrome, Multiple congenital exostosis
| Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:44228374
- GRCh38:
- Chr11:44206824
| EXT2 | | Exostoses, multiple, type 2, Seizures-scoliosis-macrocephaly syndrome, Exostoses, multiple, type 2
| Likely benign (Sep 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:44255681
- GRCh38:
- Chr11:44234131
| EXT2 | Y608C, Y641C, Y618C | Exostoses, multiple, type 2 | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:44130778
- GRCh38:
- Chr11:44109228
| EXT2 | M191V, M224V | Exostoses, multiple, type 2, Seizures-scoliosis-macrocephaly syndrome | Uncertain significance (Jul 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:44219466
- GRCh38:
- Chr11:44197916
| EXT2, LOC126861201 | R498*, R465*, R475* | Exostoses, multiple, type 2, not provided, Seizures-scoliosis-macrocephaly syndrome, Exostoses, multiple, type 2 | Conflicting interpretations of pathogenicity (Aug 9, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:44148445
- GRCh38:
- Chr11:44126895
| EXT2 | V340D, V373D | Seizures-scoliosis-macrocephaly syndrome, Exostoses, multiple, type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:44148443
- GRCh38:
- Chr11:44126893
| EXT2 | | Exostoses, multiple, type 1, Exostoses, multiple, type 2, Exostoses, multiple, type 2, Seizures-scoliosis-macrocephaly syndrome, not provided | Benign/Likely benign (Jul 7, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:44129781
- GRCh38:
- Chr11:44108231
| EXT2 | | Exostoses, multiple, type 1, Seizures-scoliosis-macrocephaly syndrome, Exostoses, multiple, type 2, not provided, Exostoses, multiple, type 2 | Benign/Likely benign (Oct 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:44129273
- GRCh38:
- Chr11:44107723
| EXT2 | S37L, S4L | Seizures-scoliosis-macrocephaly syndrome, Exostoses, multiple, type 2 | Conflicting interpretations of pathogenicity (Oct 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:44135806
- GRCh38:
- Chr11:44114256
| EXT2 | Y233C, Y266C | Seizures-scoliosis-macrocephaly syndrome, Exostoses, multiple, type 2, not provided, Exostoses, multiple, type 2 | Uncertain significance (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:44146500-44146501
- GRCh38:
- Chr11:44124950-44124951
| EXT2 | H336fs, H303fs | not provided, Exostoses, multiple, type 2, Exostoses, multiple, type 2, Seizures-scoliosis-macrocephaly syndrome | Pathogenic (Feb 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:44129522
- Chr11:44129545
- GRCh38:
- Chr11:44107972
- Chr11:44107995
| EXT2, EXT2 | M120R, M87R, R95C, R128C | Seizures-scoliosis-macrocephaly syndrome | Pathogenic (Oct 1, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr11:44151577
- GRCh38:
- Chr11:44130027
| EXT2 | | Exostoses, multiple, type 1, Seizures-scoliosis-macrocephaly syndrome, not specified, not provided, Exostoses, multiple, type 2 | Benign (Jul 7, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:44193165
- GRCh38:
- Chr11:44171615
| EXT2 | R393Q, R426Q | Seizures-scoliosis-macrocephaly syndrome, not provided, Exostoses, multiple, type 2
| Conflicting interpretations of pathogenicity (Oct 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:44148448
- GRCh38:
- Chr11:44126898
| EXT2 | P341L, P374L | Exostoses, multiple, type 2, Seizures-scoliosis-macrocephaly syndrome, not provided, Exostoses, multiple, type 2 | Conflicting interpretations of pathogenicity (Oct 8, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:44255774
- GRCh38:
- Chr11:44234224
| EXT2 | T639M, T672M, T649M | Seizures-scoliosis-macrocephaly syndrome, Exostoses, multiple, type 2 | Conflicting interpretations of pathogenicity (Aug 21, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:44135787
- GRCh38:
- Chr11:44114237
| EXT2 | D227N, D260N | Seizures-scoliosis-macrocephaly syndrome, Exostoses, multiple, type 2, not provided, Exostoses, multiple, type 2 | Pathogenic (Jan 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:44129776
- GRCh38:
- Chr11:44108226
| EXT2 | Q172*, Q205* | Seizures-scoliosis-macrocephaly syndrome, Exostoses, multiple, type 2, Hereditary cancer-predisposing syndrome, not provided, Exostoses, multiple, type 2 | Pathogenic (May 19, 2022) | criteria provided, multiple submitters, no conflicts |